Nephrogenic anaemia – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Tue, 02 Jun 2026 04:07:59 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Nephrogenic anaemia – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease https://clinicaltrials.eu/trial/study-on-roxadustat-for-treating-anemia-in-children-with-chronic-kidney-disease/ Wed, 29 Apr 2026 14:26:16 +0000 https://clinicaltrials.eu/trial/study-on-roxadustat-for-treating-anemia-in-children-with-chronic-kidney-disease/ This clinical trial is focused on studying the treatment of anemia in children and adolescents who have Chronic Kidney Disease (CKD). Anemia is a condition where the body does not have enough healthy red blood cells to carry oxygen, which can make a person feel tired and weak. CKD is a long-term condition where the kidneys do not work as well as they should. The study will use a medication called roxadustat, which is taken as a tablet. Roxadustat is being tested to see how well it works and how safe it is for treating anemia in young patients with CKD.

In this study, participants will take roxadustat tablets for a period of time, and their health will be monitored to see how the medication affects their anemia. The study will also compare roxadustat to other treatments that are commonly used for anemia, such as methoxy polyethylene glycol-epoetin beta, epoetin alfa, and darbepoetin alfa. These are medications that help the body produce more red blood cells. Some participants may receive a placebo, which looks like the real medication but does not contain any active ingredients.

The purpose of the study is to evaluate the effectiveness and safety of roxadustat in treating anemia in children and adolescents with CKD. Participants will be closely monitored by healthcare professionals throughout the study to ensure their safety and to gather information on how the medication affects their condition. The study aims to provide valuable information that could help improve the treatment of anemia in young patients with CKD in the future.

]]> Ogólnopolskie Stowarzyszenie Moje Nerki https://clinicaltrials.eu/organisation/ogolnopolskie-stowarzyszenie-moje-nerki/ Wed, 29 Apr 2026 13:34:19 +0000 https://clinicaltrials.eu/organisation/ogolnopolskie-stowarzyszenie-moje-nerki/ The National Association “My Kidneys” (OSMN) is a nationwide public benefit organization. It brings together patients with chronic kidney disease (CKD), dialysis patients, those in the pre-dialysis stage, kidney transplant recipients, as well as their families and caregivers from all over the country. The association’s mission is primarily education and the promotion of prevention and the idea of transplantation, organizing free tests and lectures on the occasion of World Kidney Day, raising awareness of CKD, and providing support for patients.

]]>